Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Grover, Sandeep, Nandita Hazari, Subho Chakrabarti, and Ajit Avasthi. "Metabolic disturbances, side effect profile and effectiveness of clozapine in adolescents." Indian journal of psychological medicine 38, no. 3 (2016): 224-233. |
|
Warren, Kimberly R., M. Patricia Ball, Stephanie Feldman, Fang Liu, Robert P. McMahon, and Deanna L. Kelly. "Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia." Biological research for nursing 13, no. 4 (2011): 383-390. |
|
Nebhinani, Naresh, Sandeep Grover, Subho Chakrabarti, Natasha Kate, and Ajit Avasthi. "A longitudinal study of change in prevalence of metabolic syndrome and metabolic disturbances 3 months after Clozapine therapy." J Ment Health Human Behav 18, no. 1 (2013): 9-17. |
|
Delaney, Kathleen R., Karen M. Robinson, and Linda Chafetz. "Development of integrated mental health care: Critical workforce competencies." Nursing outlook 61, no. 6 (2013): 384-391. |
|
Methapatara, Waritnan, and Manit Srisurapanont. "Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: A 12?week, randomized, controlled trial." Psychiatry and clinical neurosciences 65, no. 4 (2011): 374-380. |
|
Hyde, Natalie, Seetal Dodd, Kamalesh Venugopal, Christa Purdie, Michael Berk, and Adrienne O�Neil. "Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study." Current drug safety 10, no. 2 (2015): 125-131. |
|
Grover, Sandeep, Srinivas Balachander, Subho Chakarabarti, and Ajit Avasthi. "Prescription practices and attitude of psychiatrists towards clozapine: a survey of psychiatrists from India." Asian journal of psychiatry 18 (2015): 57-65. |
|
Grover, Sandeep, Naresh Nebhinani, Subho Chakrabarti, Ajit Avasthi, and Parmanand Kulhara. "Metabolic syndrome among patients receiving clozapine: A preliminary estimate." Indian journal of pharmacology 43, no. 5 (2011): 591. |
|
Shoja Shafti, Saeed. "Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study." Psychiatry and Clinical Psychopharmacology 27, no. 3 (2017): 235-242. |
|
Maayan, Nicola, Karla Soares-Weiser, Jun Xia, and Clive E. Adams. "Antipsychotic combinations for schizophrenia." The Cochrane database of systematic reviews 2 (2011). |
|
Matar, Hosam E., Muhammad Qutayba Almerie, and Stephanie J. Sampson. "Fluphenazine (oral) versus placebo for schizophrenia." Cochrane Database of Systematic Reviews 6 (2018). |
|
Ortiz?Orendain, Javier, Santiago Castiello?de Obeso, Luis Enrique Colunga?Lozano, Yue Hu, Nicola Maayan, and Clive E. Adams. "Antipsychotic combinations for schizophrenia." Cochrane Database of Systematic Reviews 6 (2017). |
|
David, Anthony, Clive E. Adams, Maurice Eisenbruch, Seema N. Quraishi, and John Rathbone. "Depot fluphenazine decanoate and enanthate for schizophrenia." Cochrane database of systematic reviews 2 (2004). |
|
Chakrabarti, Subho. "Clozapine resistant schizophrenia: Newer avenues of management." World Journal of Psychiatry 11, no. 8 (2021): 429. |
|
Jones, Chris, David Hacker, Irene Cormac, Alan Meaden, and Claire B. Irving. "Cognitive behaviour therapy versus psychosocial treatments for schizophrenia." Cochrane Database of Systematic Reviews 9 (2010). |
|
Morrison, Anthony P., Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie et al. "Cognitive-behavioural therapy for clozapine-resistant schizophrenia: The FOCUS RCT." Health Technology Assessment (2019). |
|
Lee, N. Y., M. S. Roh, S. H. Kim, D. C. Jung, H. Y. Yu, K. H. Sung, I. W. Chung et al. "The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia." International clinical psychopharmacology 28, no. 2 (2013): 71-79. |
|
Pijnenborg, Gerdina HM, Rozanne JM van Donkersgoed, Anthony S. David, and Andr� Aleman. "Changes in insight during treatment for psychotic disorders: a meta-analysis." Schizophrenia Research 144, no. 1-3 (2013): 109-117. |
|
Jones, Christopher, David Hacker, Alan Meaden, Irene Cormac, Claire B. Irving, Jun Xia, Sai Zhao, Chunhu Shi, and Jue Chen. "Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia." Cochrane Database of Systematic Reviews 11 (2018). |
|
DANEAU, St�phanie, Johanne GOUDREAU, and Catherine SARRAZIN. "METHODOLOGIE." (2020). |
|